Evidence Synthesis
TITANBIO's 54.25% gross margin accelerated to, up from 18.8%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 4 Sept 2026, 15:07
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
TITANBIO's 54.25% gross margin accelerated to, up from 18.8%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 54.25 % | 18.8 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 18.8 % | 15.48 | ▲ |
| REVENUE_GROWTH_YOY | 27.3 % | 58.4 | ▼ |
| PRICE_CHANGE_PERCENT | 0.816 % | — | - |
| DAILY_VOLUME | 43,194 shares | 25,542 | ▲ |
| CLOSE_PRICE | 438.75 INR | 435.2 | ▲ |